[go: up one dir, main page]

HK1104460A1 - Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases - Google Patents

Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases

Info

Publication number
HK1104460A1
HK1104460A1 HK07109654.1A HK07109654A HK1104460A1 HK 1104460 A1 HK1104460 A1 HK 1104460A1 HK 07109654 A HK07109654 A HK 07109654A HK 1104460 A1 HK1104460 A1 HK 1104460A1
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
medicament
manufacture
treatment
infectious diseases
Prior art date
Application number
HK07109654.1A
Other languages
English (en)
Inventor
Kjaeldgaard Giwercman Birgit
Original Assignee
Bkg Pharma Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bkg Pharma Aps filed Critical Bkg Pharma Aps
Publication of HK1104460A1 publication Critical patent/HK1104460A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
HK07109654.1A 2004-04-30 2007-09-05 Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases HK1104460A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400680 2004-04-30
DKPA200401716 2004-11-08
PCT/DK2005/000294 WO2005105145A1 (en) 2004-04-30 2005-04-29 Treatment of infectious diseases

Publications (1)

Publication Number Publication Date
HK1104460A1 true HK1104460A1 (en) 2008-01-18

Family

ID=34965444

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07109654.1A HK1104460A1 (en) 2004-04-30 2007-09-05 Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases

Country Status (13)

Country Link
US (1) US20080318970A1 (xx)
EP (2) EP1744781B1 (xx)
JP (2) JP5026255B2 (xx)
CN (1) CN1976723B (xx)
AU (1) AU2005237208B2 (xx)
CA (1) CA2564684C (xx)
DK (1) DK1744781T3 (xx)
EA (1) EA016803B1 (xx)
ES (1) ES2390226T3 (xx)
HK (1) HK1104460A1 (xx)
MX (1) MXPA06012566A (xx)
NO (1) NO20065469L (xx)
WO (1) WO2005105145A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008080398A1 (en) * 2007-01-05 2008-07-10 Bkg Pharma Aps Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases
EP2246349A1 (en) * 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
CN103781481B (zh) 2011-08-02 2018-12-14 亥姆霍兹慕尼黑中心-德国环境健康研究中心 (Gmbh) 吩噻嗪衍生物对malt1蛋白酶的选择性抑制
WO2013043744A2 (en) 2011-09-21 2013-03-28 Inception 1, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
AU2012316085A1 (en) * 2011-09-29 2014-05-22 Emory University Sphingosine analogs, compositions, and methods related thereto
RU2663289C2 (ru) * 2012-11-26 2018-08-03 Юниверсити Оф Кейптаун Производные фенотиазина и их применение против туберкулеза
KR101798176B1 (ko) * 2014-12-16 2017-11-15 주식회사 엠디헬스케어 세균 유래의 나노소포체를 이용한 세균성 감염질환 원인균 동정방법
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
MX2018016339A (es) 2016-06-23 2019-09-04 Bioimics Ab Compuestos heterociclicos antiinfecciosos y sus usos.
WO2018070874A1 (en) * 2016-10-12 2018-04-19 Rijksuniversiteit Groningen Means and methods for reducing or avoiding antibiotic resistance and spread of virulence in human pathogens
EP3958975A1 (en) * 2019-04-24 2022-03-02 Københavns Universitet New class of antibiotics having low mic-values towards different strains of bacteria
CN112353805A (zh) * 2020-11-17 2021-02-12 北京化工大学 氟哌噻吨在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE578983A (xx) 1958-05-29
DE1210890B (de) 1960-03-07 1966-02-17 Smith & Kline & French Lab Verfahren zur Herstellung von Trifluormethyl-xanthen- oder thioxanthenderivaten
HU190078B (en) * 1983-03-25 1986-08-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing new antibacterial pharmaceutical composition and/or food-premix
AU625071B2 (en) * 1988-04-20 1992-07-02 Merrell Dow Pharmaceuticals Inc. N-alkylamino derivatives of aromatic, tricyclic compounds in the treatment of drug-resistant protozoal infections
US6569853B1 (en) 2000-11-06 2003-05-27 Combinatorx, Incorporated Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders
US6989396B2 (en) * 2001-04-12 2006-01-24 The Board Of Trustees Of The University Of Illinois Tropane alkaloid multidrug resistance inhibitors from Erythroxylum pervillei and use of the same
WO2002089810A1 (en) * 2001-05-07 2002-11-14 United States Army Medical Research And Materiel Command Chemosensitizing agents against chloroquine resistant plasmodium falciparum and methods of making and using thereof
AU2002325192B2 (en) 2001-07-06 2008-05-22 Veloxis Pharmaceuticals, Inc. Controlled agglomeration
US20030229082A1 (en) * 2002-01-16 2003-12-11 The Regents Of The University Of California Inhibition of RNA function
AU2003205543A1 (en) 2003-01-14 2004-08-10 Lifecycle Pharma A/S Dry dispersions
ES2377016T3 (es) * 2003-11-13 2012-03-21 Noa Sic Aps Tioridazina y derivados de la misma para invertir la resistencia a los fármacos anti-microbianos

Also Published As

Publication number Publication date
EP1744781B1 (en) 2012-07-04
WO2005105145A1 (en) 2005-11-10
AU2005237208B2 (en) 2009-12-03
AU2005237208A1 (en) 2005-11-10
EP2260870A2 (en) 2010-12-15
DK1744781T3 (da) 2012-10-15
CA2564684C (en) 2010-10-26
EA200601889A1 (ru) 2007-06-29
JP5026255B2 (ja) 2012-09-12
NO20065469L (no) 2007-01-24
EP1744781A1 (en) 2007-01-24
MXPA06012566A (es) 2007-05-09
CA2564684A1 (en) 2005-11-10
US20080318970A1 (en) 2008-12-25
ES2390226T3 (es) 2012-11-07
EP2260870A3 (en) 2012-12-26
EA016803B1 (ru) 2012-07-30
JP2012082219A (ja) 2012-04-26
JP2007535510A (ja) 2007-12-06
CN1976723A (zh) 2007-06-06
CN1976723B (zh) 2010-12-29

Similar Documents

Publication Publication Date Title
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
TWI369210B (en) Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
IL178815A0 (en) The treatment of respiratory disease
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL184124A0 (en) Medicaments for the treatment or prevention of fibrotic diseases
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
GB0410399D0 (en) The treatment of respiratory disease
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases
EP1789034A4 (en) COMPOUNDS HAVING A DIPHENYL STRUCTURE FOR THE TREATMENT OF IMMUNE DISEASES
PT1670482E (pt) Utilização de ciclesonida para o tratamento de doenças respiratórias
GB0523961D0 (en) The treatment of ophthalmic diseases
SI1714647T1 (sl) Uporaba agomelatina pri izdelavi zdravila za zdravljenje bipolarnih motenj
HK1119064A1 (en) Use of azithromycin for the production of a medicament for treatment of ocular infections
HU0500145D0 (en) Composition for the treatment of oral diseases
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
ZA200606780B (en) Compounds for the treatment of diseases
IL191208A (en) Use of phenofibrate or its derivative for the preparation of a drug for the treatment of diabetic retinopathy
GB0523964D0 (en) The treatment of ophthalmic diseases
ZA200900556B (en) Use of flumazenil in the manufacture of a medicament for the treatment of depressive disorders
IL186916A0 (en) Use of insp052 polypeptide for the preparation of a medicament for treating diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160429